The antibiotic Gentamicin (famous for its efficacy and reputed for its ototoxicity) may modify the FTD PGRN R493X gene mutation that has been related to rapid illness course with predominant right-sided atrophy – as here demonstrated in this early stage animal study (full research paper).
